KPOC - Merger Arbitrage Mondays - Exact Sciences Corporation Acquires Genomic Health

Merger activity decreased last week with three new deals announced and ten pending deals closing.

Deal Statistics:

New Deals:

1. The acquisition of Genomic Health ([[GHDX]]) by Exact Sciences Corporation ([[EXAS]]) for $2.8 billion in a cash-plus-stock deal. Under the terms of the agreement, for each share of Genomic Health common stock they own, Genomic Health stockholders will receive $27.50 in cash and $44.50 in shares of Exact Sciences stock, subject to a 10% collar centered on Exact Sciences’ volume-weighted average price for the 45 trading days ended July 26, 2019. We added GHDX as a

Read more ...